Private equity firm Carlyle Group is in exclusive talks to acquire Baxter International's kidney care spinoff Vantive for more than $4 billion, including debt, a person familiar with the matter told Reuters on Friday.
The parties had entered exclusive negotiations in late June, the person said, adding that a deal could be announced in the coming weeks.
Medical device maker Baxter said in March it had been in discussions with select private equity investors to explore a potential sale of the kidney care unit more than a year after it announced plans to separate the unit amid supply-chain challenges and weak demand for dialysis operations.
Baxter had said it plans to separate the unit in the second half of the year.
https://finance.yahoo.com/news/carlyle-talks-buy-baxters-kidney-185433555.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.